GlassScriptPhysician profile
Mary Katz
NPI 1922377910
$9,907.68
in general payments reported to CMS, 2019-2025
46 companies · $1,709 in 2025
The $1,709 reported for 2025 was more than what 91% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $734 · 2022: $2,356 · 2023: $2,107 · 2024: $3,002 · 2025: $1,709.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $6,642 · Education: $175.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $6,641.96 |
| Education | $175.46 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,100.16 | 2022-2025 | |
| Regeneron Healthcare Solutions, INC. | $817.97 | 2021-2025 | Dupixent |
| Glaxosmithkline, LLC. | $660.51 | 2021-2023 | Nucala, Trelegy Ellipta |
| Novartis Pharmaceuticals Corporation | $563.45 | 2021-2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $547.04 | 2021-2023 | Jardiance, Spiriva |
| Incyte Corporation | $528.66 | 2023-2025 | Opzelura |
| Astrazeneca Pharmaceuticals LP | $509.17 | 2021-2023 | Fasenra, Tezspire |
| Genzyme Corporation | $477.43 | 2021-2024 | |
| Dermavant Sciences, INC. | $403.61 | 2023-2024 | Vtama |
| Arcutis Biotherapeutics, INC. | $398.66 | 2023-2025 | Zoryve |
| Janssen Biotech, INC. | $387.17 | 2023-2025 | Tremfya, Stelara, Simponi |
| E.R. Squibb & Sons, L.L.C. | $384.45 | 2023-2025 | Sotyktu |
| Amgen INC. | $373.50 | 2022-2025 | Otezla, Otezla, Tezspire |
| Lilly USA, LLC | $309.83 | 2021-2025 | Taltz, Olumiant, Ebglyss |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $306.01 | 2024-2025 | Siliq, Arazlo, Targretin |
Show all 46 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mary Katz listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.